• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROVENTION, INC. AZUR CX 35 DETACHABLE; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROVENTION, INC. AZUR CX 35 DETACHABLE; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION Back to Search Results
Model Number 45-750617
Medical Device Problem Code Premature Separation (4045)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/26/2024
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that a premature detachment coil was removed and new one delivered, case completed.No patient injury was reported.
 
Additional Manufacturer Narrative
The device was returned to the manufacturer for evaluation.The investigation is ongoing.Upon completion of the investigation, a supplemental mdr will be submitted.A search for non-conformances associated with this part/lot number combination did not reveal any production-related issues relevant to the complaint that occurred during manufacturing of the device.The instructions for use (ifu) identifies premature coil detachment as a potential complication associated with the use of the device.
 
Additional Manufacturer Narrative
Items returned for evaluation: implant; introducer; shrink lock.Items not returned for evaluation: pusher; dispenser hoop; catheter.The visual analysis of the returned device found that the implant was separated from the pusher and partially stuck within the distal end of the introducer.A different coil pusher loaded in its introducer with no implant attached was returned, the reported azur pusher was not returned for evaluation.The investigation of the implant found that the monofilament at the tie knot was broken, which indicates that the device experienced a tensile break.The investigation of the returned azur coil system found the implant separated from the pusher and partially stuck within the distal end of the introducer.The azur pusher was not returned for evaluation.The investigation found that the implant's monofilament showed a tensile break shape at the tip, which is consistent with the device experiencing force that exceeded the strength of the monofilament causing the implant to separate from the pusher.
 
Event or Problem Description
It was reported that a premature detachment coil was removed and new one delivered, case completed.It was reported that the patient was stable and no injury was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AZUR CX 35 DETACHABLE
Common Device Name
DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION
Manufacturer (Section D)
MICROVENTION, INC.
35 enterprise
aliso viejo CA 92656
Manufacturer Contact
terrence callahan
35 enterprise
aliso viejo, CA 92656
7142478000
MDR Report Key20276384
Report Number2032493-2024-00699
Device Sequence Number12616201
Product Code KRD
UDI-Device Identifier00812636021041
UDI-Public(01)00812636021041(11)240322(17)290228(10)0000556782
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
K151358
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 10/24/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number45-750617
Device Lot Number0000556782
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/16/2024
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/26/2024
Supplement Date Received by Manufacturer09/30/2024
Initial Report FDA Received Date09/23/2024
Supplement Report FDA Received Date10/24/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/21/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-